Seeing Is Believing
ZEAL is currently covered by 1 analysts with an average price target of $10.99. This is a potential upside of $10.99 (0%) from yesterday's end of day stock price of $0.
Zealand Pharma A/S ADR's activity chart (see below) currently has 11 price targets and 11 ratings on display. The stock rating distribution of ZEAL is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 98 days.
Highest price target for ZEAL is $10, Lowest price target is $10, average price target is $10.99.
Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 13-May-2022. First documented stock forecast 05-Sep-2017.
Currently out of the existing stock ratings of ZEAL, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
32
$14.41 (81.92%)
42
1 years 11 months 15 days ago
0/2 (0%)
$21.91 (217.15%)
Buy
35
$17.41 (98.98%)
38
4 years 28 days ago
6/6 (100%)
$0.5 (1.45%)
101
Sell
42
$24.41 (138.77%)
32
4 years 5 months 13 days ago
3/3 (100%)
$10.55 (46.64%)
193
What is ZEAL (Zealand Pharma A/S ADR) average time for price targets to be met?
Which analyst has the current highest performing score on ZEAL (Zealand Pharma A/S ADR) with a proven track record?
Which analyst has the current lower performing score on ZEAL (Zealand Pharma A/S ADR) with a proven track record?
Which analyst has the most public recommendations on ZEAL (Zealand Pharma A/S ADR)?
Which analyst is the currently most bullish on ZEAL (Zealand Pharma A/S ADR)?
Which analyst is the currently most reserved on ZEAL (Zealand Pharma A/S ADR)?